Halozyme Therapeutics
HALO
#2381
Rank
NZ$12.87 B
Marketcap
NZ$109.08
Share price
1.93%
Change (1 day)
-3.55%
Change (1 year)

Market capitalization of Halozyme Therapeutics (HALO)

Market cap: NZ$12.87 Billion

As of March 2026 Halozyme Therapeutics has a market cap of NZ$12.87 Billion. This makes Halozyme Therapeutics the world's 2381th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Halozyme Therapeutics from 2004 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$12.87 B-7.94%
2025NZ$13.98 B28.79%
2024NZ$10.85 B40.64%
2023NZ$7.72 B-36.29%
2022NZ$12.11 B46.21%
2021NZ$8.28 B3.58%
2020NZ$8.00 B122.33%
2019NZ$3.59 B14.02%
2018NZ$3.15 B-22.27%
2017NZ$4.06 B119.88%
2016NZ$1.84 B-43.08%
2015NZ$3.24 B109.56%
2014NZ$1.54 B-25.89%
2013NZ$2.08 B127.26%
2012NZ$0.91 B-27.24%
2011NZ$1.26 B22.37%
2010NZ$1.03 B39.35%
2009NZ$0.74 B-5.72%
2008NZ$0.78 B8.69%
2007NZ$0.72 B-7.93%
2006NZ$0.78 B389.59%
2005NZ$0.16 B5.75%
2004NZ$0.15 B

End of Day market cap according to different sources

On Mar 25th, 2026 the market cap of Halozyme Therapeutics was reported to be:

NZ$12.92 Billion
by Nasdaq info icon info icon
NZ$12.87 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
NZ$997.34 B 7,647.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$267.66 B 1,979.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$1.414 T 10,888.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$193.36 B 1,402.02%๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
NZ$15.19 B 18.02%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
NZ$1.21 B-90.59%๐Ÿ‡บ๐Ÿ‡ธ USA